Format

Send to

Choose Destination
Pediatr Blood Cancer. 2013 May;60(5):889-91. doi: 10.1002/pbc.24476. Epub 2013 Feb 28.

Essential medicines for pediatric oncology in developing countries.

Author information

1
Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77094, USA. psmehta@txch.org

Abstract

The burden of cancer in children in low and middle income countries (LMICs) is substantial, comprising at least 80% of incident cases globally, and an even higher proportion of cancer-related deaths. With survival rates exceeding 80% in high income countries, it is imperative to transfer these successes to LMICs. A major challenge is the poor availability of safe, cost-effective chemotherapy. A list of 51 drugs-chemotherapeutics, infectious disease agents, and supportive care medications-is proposed as essential to improving the survival of children with cancer in LMICs with an additional 13 drugs identified as being of further value.

PMID:
23450774
DOI:
10.1002/pbc.24476
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center